COMMUNIQUÉ DE PRESSE publié le 10/09/2024 à 16:00, il y a 2 années Jaguar Health Appoints Industry Veteran to Head Sales for Company’s Commercialized Oncology and HIV Products Including October 2024 Launch of Gelclair for Cancer Supportive Care Jaguar Health, Inc. appoints Susan Krizancic as National Sales Director for Napo Pharmaceuticals, preparing for FDA-approved Gelclair® oral mucositis product launch in October 2024 Jaguar Health FDA-approved Gelclair Susan Krizancic National Sales Director
COMMUNIQUÉ DE PRESSE publié le 10/09/2024 à 15:51, il y a 2 années Original-Research: Enapter AG (von First Berlin Equity Research GmbH): Buy First Berlin Equity Research bestätigt Kaufempfehlung für Enapter AG und Kursziel von 11 Euro nach starken Geschäftszahlen. Hohe Bruttomarge zeigt Wettbewerbsfähigkeit Kursziel Kaufempfehlung Enapter AG Geschäftszahlen Bruttomarge
COMMUNIQUÉ DE PRESSE publié le 10/09/2024 à 15:45, il y a 2 années ASTA-USA Discusses the Dark Side of AI and How Medical Translation Errors Have Harmed or Killed Dozens of Patients Use of web-based translation tools has led to medical errors and patient harm. ASTA-USA advises healthcare to use professional human translators to avoid risks. Investigation shows fatalities due to flawed translations ASTA-USA Translation Tools Medical Errors Patient Harm Professional Translators
COMMUNIQUÉ DE PRESSE publié le 10/09/2024 à 15:30, il y a 2 années JOST presents growth strategy and its 2030 ambitions JOST presents growth strategy aiming to be No. 1 supplier for commercial vehicles worldwide, targeting over EUR 2 billion sales by 2030 with increased profitability and shareholder value Growth Strategy Shareholder Value Profitability JOST Werke SE Sales Target
COMMUNIQUÉ DE PRESSE publié le 10/09/2024 à 15:24, il y a 2 années Virbac : Déclaration d'actions et de droits de vote 08/2024 Déclaration d'actions et de droits de vote pour Virbac sur Euronext Paris. Total brut de droits de vote : 12 776 794, total net : 12 693 388 Euronext Paris Droits De Vote Santé Animale VIRBAC Déclaration D'actions
COMMUNIQUÉ DE PRESSE publié le 10/09/2024 à 15:24, il y a 2 années Virbac : Declaration of the number of shares and voting rights 08/2024 Announcement of total shares and voting rights on Euronext Paris with ISIN code FR0000031577 for Virbac. Net total voting rights: 12,693,388 Euronext Paris Voting Rights Shares ISIN Code VIRBAC
COMMUNIQUÉ DE PRESSE publié le 10/09/2024 à 15:20, il y a 2 années CORRECTION: BlackBerry to Host Investor Day BlackBerry Limited to host Investor Day on October 16, 2024, providing insight into future plans and progress in IoT and Cybersecurity divisions. Event details available for public webcast participation Iot Cybersecurity Investor Day Webcast BlackBerry Limited
COMMUNIQUÉ DE PRESSE publié le 10/09/2024 à 15:17, il y a 2 années Virbac : Declaration of the number of shares and voting rights 07/2024 Declaration of the number of shares and voting rights for VIRBAC on Euronext Paris. Total voting rights: 12,776,794. Net voting rights: 12,693,388 Euronext Paris Voting Rights Shares Financial Market VIRBAC
COMMUNIQUÉ DE PRESSE publié le 10/09/2024 à 15:17, il y a 2 années Virbac : Déclaration d'actions et de droits de vote 07/2024 Déclaration d'actions et de droits de vote concernant Virbac sur Euronext Paris. Nombre total d'actions : 8 458 000. Total brut de droits de vote : 12 776 794 Euronext Paris Déclaration Droits De Vote Actions VIRBAC
COMMUNIQUÉ DE PRESSE publié le 10/09/2024 à 15:05, il y a 2 années Form 8.3 - The Vanguard Group, Inc.: International Paper Company The Vanguard Group, Inc. discloses 11.77% ownership of International Paper Company's common stock in Form 8.3 filing on 10-Sep-2024 Form 8.3 Disclosure Vanguard Group Ownership International Paper Company
Publié le 11/09/2026 à 07:00, il y a 1 heure 32 minutes BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Publié le 11/09/2026 à 07:00, il y a 1 heure 32 minutes BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Publié le 10/09/2026 à 19:30, il y a 13 heures 2 minutes Availability of the 2026 Interim Financial Report
Publié le 11/09/2026 à 04:00, il y a 4 heures 32 minutes Torq Announces Debt Settlement and Corporate Update
Publié le 10/09/2026 à 22:25, il y a 10 heures 7 minutes Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Publié le 10/09/2026 à 15:20, il y a 17 heures 12 minutes MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Publié le 10/09/2026 à 15:00, il y a 17 heures 32 minutes All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Publié le 11/09/2026 à 08:15, il y a 17 minutes EQS-Adhoc: Airbus SE: Airbus commences limited share buyback to support future employee share ownership plan activities and equity-based compensation
Publié le 11/09/2026 à 08:02, il y a 30 minutes PUMA CCO Matthias Baeumer to step down from Management Board
Publié le 11/09/2026 à 07:30, il y a 1 heure 2 minutes NAGRAVISION and MediaTek Broaden Partnership to Redefine Content Security for Premium Content on Connected TVs
Publié le 11/09/2026 à 00:05, il y a 8 heures 27 minutes Club Offers for Travel Enthusiasts in Germany